Quick Overview: Michael Maylahn, Founder & CEO of Stasis, joins our Proxima Clinical Research is proud to be a sponsor this year at the LSI Emerging Receiving funding for your medical product can be difficult if you are not FDA-approved. In an
Medtech Summit Hybrid Event 20 - Detailed Overview & Context
Michael Maylahn, Founder & CEO of Stasis, joins our Proxima Clinical Research is proud to be a sponsor this year at the LSI Emerging Receiving funding for your medical product can be difficult if you are not FDA-approved. In an This week, we hear from Wolfgang Goetz, who highlights the global significance of the Georgia Strados Labs was a presenting company at the LSI 2021 Emerging Clinical efficacy is no longer the differentiator in
With over 450 medical device, diagnostics and combination product professionals from across 250+ companies, the Martin Grasse, CEO of Gradient Denervation Technologies — a medical device company advancing innovative solutions in ...
